App-Quantinova.ai

Incidence of incidental and symptomatic venous thromboembolism (VTE) and Khoranas score in ambulatory pancreatic cancer patients receiving chemotherapy.

Andres Jesus Muoz Martin - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Practice of venous thromboembolism (VTE) prophylaxis in hospitalized cancer patients at a comprehensive cancer center.

Maria Alma Rodriguez - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

Safety of EBUS TBNA in patients with mediastinal and hilar adenopathy taking clopidogrel.

Rabih Bechara - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Clopidogrel bisulfate

Clinical significance of the neutrophillymphocyte ratio in venous thromboembolism patients with lung cancer.

Se-Il Go - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: Results of the CAVECCAS study.

Philippe Debourdeau - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Protein C

Risk factors for cancer-related venous thromboembolism in ambulatory patients.

Chiara Alessandra Cella - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Mofezolac

Association of circulating tumor cells with venous thromboembolism in advanced non-small cell lung cancer.

Robert Lewin Metcalf - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor, and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma.

Mustafa Bozkurt - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Incidence of cardiovascular events in the real-world population of cancer patients treated with targeted therapies.

Jonathan G Zaroff - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Bevacizumab

Venous thromboembolism (VTE) and glioblastoma.

Jacob Joseph Mandel - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Temozolomide

Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: A prospective randomized trial.

Kyo Young Song - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Enoxaparin

Development of a phase 2 study of the aurora kinase-A inhibitor alisertib (MLN8237) in pretreated patients (pts) with urothelial cancer (UC).

Andrea Necchi - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

dacomitinib

Predictors and outcomes of venous thromboembolism (VTE) in hospitalized lung cancer patients: A nationwide inpatient sample (NIS) database analysis.

Conor Ernst Steuer - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Thrombosis in a population of phase I trial patients.

Alan David Smith - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Incidence of venous thromboembolism (VTE) in ambulatory day oncology patients.

John Patrick Greene - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Experience of a small cancer center from Brazil with implantable port systems in the brachial veins.

Sabina B. Aleixo - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

SELECT-D: Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.

Annie Young - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

Preoperative D-dimer measurement for assessment of venous thromboembolism in colorectal cancer cases.

Kazuha Hatta - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Inferior vena cava thrombus recurrence after radical nephrectomy in renal cell carcinoma.

Caroline Kauffmann - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Impact of chemotherapy (CTX) on venous thromboembolism (VTE) and prognostic implications in patients with metastatic urinary tract tumors (UTT).

Jorge Ramos - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts